Tlwm Acquires New Shares in Globe Life Inc. $GL

Tlwm purchased a new position in shares of Globe Life Inc. (NYSE:GL) in the 2nd quarter, Holdings Channel reports. The institutional investor purchased 4,700 shares of the company’s stock, valued at approximately $840,000.

Other institutional investors have also recently modified their holdings of the company. Vanguard Group Inc. raised its holdings in shares of Globe Life by 0.9% in the fourth quarter. Vanguard Group Inc. now owns 10,090,885 shares of the company’s stock worth $1,411,311,000 after acquiring an additional 86,349 shares during the last quarter. Invesco Ltd. lifted its holdings in shares of Globe Life by 2.7% during the 4th quarter. Invesco Ltd. now owns 3,948,676 shares of the company’s stock worth $552,262,000 after acquiring an additional 102,445 shares during the period. Dimensional Fund Advisors LP raised its stake in Globe Life by 10.2% during the first quarter. Dimensional Fund Advisors LP now owns 2,353,192 shares of the company’s stock worth $327,479,000 after purchasing an additional 217,331 shares during the period. Morgan Stanley raised its position in shares of Globe Life by 7.2% in the 4th quarter. Morgan Stanley now owns 1,860,257 shares of the company’s stock worth $260,176,000 after buying an additional 125,567 shares during the period. Finally, Arrowstreet Capital Limited Partnership raised its holdings in shares of Globe Life by 32.9% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 1,435,247 shares of the company’s stock worth $200,734,000 after purchasing an additional 355,399 shares during the period. 81.61% of the stock is currently owned by institutional investors and hedge funds.

Globe Life Stock Performance

Shares of GL stock opened at $183.81 on Thursday. The company has a market capitalization of $14.27 billion, a price-to-earnings ratio of 12.20 and a beta of 0.48. Globe Life Inc. has a 1-year low of $127.85 and a 1-year high of $191.55. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.38. The stock’s fifty day simple moving average is $173.21 and its 200-day simple moving average is $155.25.

Globe Life (NYSE:GL) last posted its quarterly earnings results on Wednesday, July 22nd. The company reported $3.61 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.67 by ($0.06). Globe Life had a return on equity of 20.73% and a net margin of 19.58%.The company had revenue of $1.60 billion during the quarter, compared to analysts’ expectations of $1.59 billion. During the same period last year, the company earned $3.05 earnings per share. Globe Life’s revenue for the quarter was up 8.0% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. On average, sell-side analysts predict that Globe Life Inc. will post 15.7 earnings per share for the current fiscal year.

Insider Buying and Selling at Globe Life

In related news, CFO Thomas Peter Kalmbach sold 21,000 shares of the company’s stock in a transaction on Thursday, July 30th. The shares were sold at an average price of $180.06, for a total value of $3,781,260.00. Following the completion of the sale, the chief financial officer directly owned 50,568 shares in the company, valued at approximately $9,105,274.08. This represents a 29.34% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Frank M. Svoboda sold 10,000 shares of the company’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $166.68, for a total value of $1,666,800.00. Following the sale, the chief executive officer owned 54,020 shares of the company’s stock, valued at approximately $9,004,053.60. This trade represents a 15.62% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 219,174 shares of company stock worth $37,675,349 over the last quarter. Insiders own 2.11% of the company’s stock.

Analyst Upgrades and Downgrades

GL has been the topic of several recent research reports. Keefe, Bruyette & Woods reduced their target price on shares of Globe Life from $192.00 to $190.00 and set an “outperform” rating on the stock in a report on Friday, July 24th. TD Cowen lifted their target price on Globe Life from $215.00 to $225.00 and gave the company a “buy” rating in a research note on Wednesday, July 22nd. Truist Financial increased their price objective on Globe Life from $180.00 to $185.00 and gave the stock a “buy” rating in a report on Friday, April 24th. Piper Sandler increased their target price on shares of Globe Life from $175.00 to $200.00 and gave the company an “overweight” rating in a research report on Wednesday, July 15th. Finally, Jefferies Financial Group lifted their price target on Globe Life from $147.00 to $166.00 and gave the company a “hold” rating in a research report on Friday, July 10th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $191.67.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.